137.57
Natera Inc 주식(NTRA)의 최신 뉴스
Natera Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
What analysts say about Natera Inc. stockSuperior trading gains - Autocar Professional
SEC Filings Archive 2025-07-22Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Natera CFO Brophy sold $83,852 in NTRA stock - Investing.com Australia
Natera CEO Chapman sells $225,928 in shares - Investing.com
Natera director Sheena Jonathan sells $12953 in shares - Investing.com Australia
Natera president Fesko sells $273k in stock - Investing.com Australia
Natera Inc: President Moshkevich sells $299k in shares - Investing.com
Natera’s chief legal officer sells $3.4 million in stock - Investing.com
Is Natera Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
What drives Natera Inc. stock priceExceptional portfolio growth - jammulinksnews.com
Natera director Sheena Jonathan sells $460k in stock By Investing.com - Investing.com Nigeria
Natera director Sheena Jonathan sells $460k in stock - Investing.com
Natera(NTRA) Shares Plunge 3.12% Amid Market, Regulatory Challenges - AInvest
When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com
Natera(NTRA) Shares Plunge 9.16% Amid Regulatory Hurdles - AInvest
What makes Natera Inc. stock price move sharplySafety First Trading Signals - beatles.ru
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera's $234M Trading Volume Ranks 433rd Amid Market Challenges - AInvest
Special master to decide whether Quinn Emanuel lawyers must contribute to $3M sanction - ABA Journal
Natera, Inc. (NTRA): A Bull Case Theory - Insider Monkey
Is Natera (NASDAQ:NTRA) Using Too Much Debt? - 富途牛牛
Quinn Emanuel Sanctioned For Ad Case 'Misrepresentations' - Law360
US judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant case - Reuters
Mike Brophy is regarded as one of Austin's best CFOs - The Business Journals
Natera's 'Signatera' detects recurrence of cancer through a blood test - Fox Business
Natera Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Natera Rings the Opening Bell - Nasdaq
Natera presents data from Latitude MRD assay study at ESMO Congress - TipRanks
Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer - New Castle News
Should You Invest in Natera (NTRA)? - Insider Monkey
Bankruptcy Judge Lets Del. Court Take Invitae Contract Fight - Law360
Natera Inks $8.25M Deal To End Prenatal Tests Suit - Law360
Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD - Yahoo Finance
Natera, Inc.(NasdaqGS: NTRA) dropped from Russell 2500 Growth Index - MarketScreener
Q1 Immuno-Oncology Earnings Review: First Prize Goes to Natera (NASDAQ:NTRA) - Yahoo Finance
Shares of Natera (NTRA) Fall as Executive Chairman Sells Company Stock - TipRanks
Natera Gains Medicare Coverage for WGS Signatera, Leerink Reaffirms Price Target - Insider Monkey
자본화:
|
볼륨(24시간):